Global Life Sciences Company Addresses M&A Growing Pains

Our client was an industry leader in clinical pathology and wanted to expand their portfolio to include esoteric pathology offerings. As they began acquiring small esoteric labs, it became evident that they could not operate efficiently with each lab utilizing separate, siloed programs. They needed to create one unified NextGen Lab Information System (LIS), but they faced a few challenges. 

0-Downtime’s expert team performed an assessment of the current state of their portfolio and looked for redundancy, usage, and health. We studied the key applications from the perspective of enterprise and operational needs, and then created a detailed rationalization roadmap that prioritized high impact, high business value functions. 

Download the case study now to discover how we were able to help our client identify and eliminate approximately 500 superfluous technologies which produced significant cost savings. 

Request Free!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.